New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 11, 2012
16:15 EDTCHK, MWW, ALR, ARNA, LNKD, JPMOn The Fly: Closing Wrap
Stocks on Wall Street were mixed, as the Nasdaq was just barely able to cling to a marginal gain for the session. Stock futures pointed to a sharply lower open following JPMorgan’s (JPM) announcement of a $2B trading loss. The futures moved off their lows prior to the open but the broader market opened in negative territory. The averages found a level where they began to build following the highest consumer confidence reading since January 2008. Each of the major indices made it to positive territory and then went into a slow drift lower, with only the Nasdaq avoiding a return to the red... ECONOMIC EVENTS: Domestically, the producer price index report showed that prices fell 0.2% in April, versus expectations for no change. The core reading, which strips out food and energy, rose 0.2%, which was in line with expectations. The University of Michigan Consumer Confidence reading was 77.8, stronger than the expected 76 reading and its highest level since January 2008. Internationally, data from China and India may signal a further weakening of the global recovery, as China reported its industrial production rose 9.3% from a year ago in April while India's industrial output fell 3.5% in March from the prior year... COMPANY NEWS: The surprising announcement from JPMorgan of a $2B trading loss at one of its divisions triggered calls for tougher bank regulation and a sell off in its shares. CEO Jamie Dimon admitted to “egregious” failures in its risk management and said the losses could deepen this quarter and beyond, sending its stock down more than 9%... MAJOR MOVERS: Among the notable gainers were Arena Pharmaceuticals (ARNA), up $2.70, or 73.77%, to $6.36, after an FDA panel backed the approval of its weight loss drug, lorcaserin, and Monster Worldwide (MWW), up $1.50, or 19.13%, to $9.33, after Reuters said the company has attracted takeover interest from LinkedIn (LNKD) and Silver Lake, but CNNMoney said sources close to LinkedIn denied that report. Noteworthy losers included Alere (ALR), down $3.28, or 14.71%, to $19.02, following its disclosure of a subpoena from the Department of Health and Human Services and the potential of broader recalls of certain products after an FDA inspection, and Chesapeake Energy (CHK), down $2.37, or 13.80%, to $14.81, after the company said it would need to delay its 10-Q filing and then made the filing shortly afterward, in which it said it may have to delay some of its asset sales... INDICES: The Dow lost 34.44, or 0.27%, to 12,820.60; the Nasdaq rose 0.18, or 0.01%, to 2,933.82; and the S&P 500 dropped 4.60, or 0.34%, to 1,353.39.
News For JPM;ARNA;MWW;LNKD;ALR;CHK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 22, 2015
16:22 EDTJPMJPMorgan CEO Dimon gets stock-based compensation of 198.5K shares for 2014
Subscribe for More Information
16:15 EDTARNAArena Pharmaceuticals initiated with a Sector Perform at RBC Capital
14:36 EDTJPMCFPB fines Wells Fargo, JPMorgan for kickback scheme
Subscribe for More Information
12:48 EDTCHKCarl Icahn believes oil prices will go lower
Subscribe for More Information
08:54 EDTALRChembio Diagnostics to acquire rights to Sure Check HIV assay in June 2016
Subscribe for More Information
06:26 EDTJPMJPMorgan CEO expected to receive $20M pay package for 2014, WSJ reports
Subscribe for More Information
05:56 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Subscribe for More Information
January 21, 2015
13:54 EDTJPMJPMorgan could lose $1.5B as a result of 2008 error, Reuters says
Subscribe for More Information
09:16 EDTARNAOn The Fly: Pre-market Movers
Subscribe for More Information
09:10 EDTARNAArena Pharmaceuticals 21M share Spot Secondary priced at $5.00
Subscribe for More Information
08:51 EDTARNAArena Pharma sells 21M shares to Leucadia's Jefferies and Piper Jaffray
Arena Pharmaceuticals (ARNA) has sold 21M shares of common stock to Jefferies, a subsidiary of Leucadia (LUK) and to Piper Jaffray (PJC) as underwriters for its previously announced public offering. The offering is expected to close on or about January 26. In addition, Arena has granted the underwriters a 30-day option to purchase up to an aggregate of 3M additional shares of common stock. Arena anticipates using the net proceeds from the offering for the clinical and preclinical development of drug candidates, for discovery research for new drug candidates, and for general corporate purposes.
06:42 EDTCHKTotal to cut spending on North Sea, U.S. shale projects, Reuters says
Subscribe for More Information
05:58 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Subscribe for More Information
January 20, 2015
18:30 EDTARNAOn The Fly: After Hours Movers
Subscribe for More Information
17:19 EDTARNAArena Pharmaceuticals cash, cash equivalents as of Dec. 31 $163.2M
Subscribe for More Information
16:05 EDTARNAArena Pharmaceuticals files to sell common stock, no amount given
Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering.
10:29 EDTCHKONGC speculated to potentially hold talks to buy Chesapeake, EnergyPlugged says
Subscribe for More Information
09:10 EDTARNAArena sees Q4 Belviq sales down 35%-45% vs. Q3
Subscribe for More Information
06:58 EDTJPMBlackRock, Fidelity close to launching 'dark pool,' WSJ reports
Some of the largest mutual fund firms, including Fidelity, BlackRock (BLK), Bank of New York Mellon (BK),, T. Row Price (TROW) and JP Morgan (JPM) are among the firms that are close to launching a new "dark pool," The Wall Street Journal reports, citing sources. The effort, which involves nine firms in total, would look to shut out sell-side trading desks and high-speed trading firms. Reference Link
06:08 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use